Mark Andrew Crowther
Mark Andrew Crowther publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Heparin-Induced Thrombocytopenia and Thrombosis.
- World rank
- #57,290 of 7,710,434 ranked researchers
- Rank in Canada
- #1,628 of 183,316
- Works
- 878
- Citations
- 69k
- Citations per work
- 78.6
What does Mark Andrew Crowther research?
Mark Andrew Crowther's work is mostly in Medicine (66%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences58366.4%
- Medicine58366.4%
- Everything else29533.6%
- 1Cardiology and Cardiovascular Medicine20% of their works
- 2Internal Medicine17% of their works
- 3Hematology12% of their works
- 4Surgery11% of their works
- 5Rheumatology3% of their works
- 6Epidemiology3% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Heparin-Induced Thrombocytopenia and Thrombosis
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Systemic Lupus Erythematosus Research
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Which keywords describe Mark Andrew Crowther's research?
The keywords of their largest research topics: Diagnosis, Antithrombotic Therapy, Pulmonary Embolism, Venous Thromboembolism, Anticoagulant Therapy, Atrial Fibrillation, Thrombosis and Hemostasis.
- Coagulopathy
- Antiphospholipid Syndrome
- Aspirin
- Immune Thrombocytopenic Purpura
- Protease-Activated Receptors
- Heparin-Induced Thrombocytopenia
- Hemostasis
- Atrial Fibrillation
- Venous Thromboembolism
- Antithrombotic Therapy
- Diagnosis
- Pulmonary Embolism
- Anticoagulant Therapy
- Thrombosis
- Inflammation
- Vaccination
- Thrombin
- Platelets
- Clopidogrel
- Systemic Lupus Erythematosus
- Trauma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Diagnosis5532 topics
- Antithrombotic Therapy5322 topics
- Pulmonary Embolism4141 topic
- Venous Thromboembolism4141 topic
- Anticoagulant Therapy3021 topic
- Atrial Fibrillation3021 topic
- Thrombosis2182 topics
- Hemostasis1972 topics
- Inflammation1972 topics
- Heparin-Induced Thrombocytopenia1391 topic
- Vaccination1391 topic
- Protease-Activated Receptors1181 topic
- Thrombin1181 topic
- Immune Thrombocytopenic Purpura791 topic
- Platelets791 topic
- Aspirin531 topic
- Clopidogrel531 topic
- Antiphospholipid Syndrome521 topic
- Systemic Lupus Erythematosus521 topic
- Coagulopathy511 topic
- Trauma511 topic
Where does Mark Andrew Crowther work?
Mark Andrew Crowther's main affiliation in the publication record is McMaster University, Canada.
How many publications and citations does Mark Andrew Crowther have?
OpenAlex counts 878 works and 69,017 citations for Mark Andrew Crowther, an h-index of 125, ranking #57,290 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Andrew Crowther. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.